Modern Weight Science

Foundayo Cost: What a Full Year Actually Comes To

CG

Claudiu Gheorghe

Editor, Modern Weight Science

Published 8 min read3 sources

Foundayo cost, worked through properly: $149 to $349 a month by dose, but the five-month climb means year one lands near $3,300 rather than the $4,188 a top-dose calculation suggests.

Foundayo runs from $149 to $349 a month self-pay depending on the dose. But because it climbs through five cheaper steps before reaching maintenance, a first year costs roughly $3,300 rather than the $4,188 you get by multiplying the top price by twelve. Year two is the expensive one. Almost every cost estimate published for this drug gets that the wrong way round.

Price by dose

DoseSelf-payWith the savings card
0.8 mg$149$149
2.5 mg$199$199
5.5 mg$299$299
9 mg$299$299
14.5 mg$349$299
17.2 mg$349$299

The card takes $50 off the top two doses and nothing off anything else. Below 14.5 mg it is worth precisely zero, which is the opposite of how these programmes are usually described. The conditions attached to the $299 price — including a 45-day refill window — are in Foundayo cost and savings card.

What year one costs

Foundayo's dose escalation is a minimum of 30 days per step, so someone titrating at the fastest permitted pace spends month 1 at $149, month 2 at $199, months 3 and 4 at $299, month 5 at $349, and months 6 to 12 at the maintenance price.

MonthsDoseMonthlySubtotal
10.8 mg$149$149
22.5 mg$199$199
3–45.5, 9 mg$299$598
514.5 mg$299 with card$299
6–1217.2 mg$299 with card$2,093
Year one, with the card$3,338
Year one, without the card$3,688
Year two onward, with the card$3,588

Year two costs more than year one, by $250, because the discount of the climb is gone. That is unusual enough to plan around, and it is the opposite of the assumption most people make.

Two conditions on those figures. Anyone who stays longer at a dose — entirely normal, and explicitly permitted by the label — pays less in year one and reaches maintenance later. And the $299 maintenance price depends on refilling within 45 days each time; miss the window and it is $349, which adds $600 across a year.

Against the alternatives

DrugMaintenance, self-payTwelve monthsMean weight loss
Foundayo$299$3,58811.1%
Wegovy tablet$299$3,588~14.9%
Wegovy pen$349$4,18814.9%
Wegovy HD 7.2 mg$399$4,788
Zepbound vials$349–$499$4,188–$5,98820.9%

Two things fall out of that table that the headline price hides.

At maintenance Foundayo is not cheaper than the Wegovy tablet. Both land at $299. Foundayo's price advantage is real during titration, when it starts at $149, and it disappears at the top dose. If you expect to be on this long-term, "the cheapest branded GLP-1" is a claim about month one.

Cost per point of weight loss favours the injections. At roughly $3,588 for 11.1%, Foundayo costs about $323 per percentage point. Zepbound at $4,188 for 20.9% is about $200. On results per dollar, the strongest drug is also the most efficient — which does not help if you will not inject it.

What changes the number

  • Insurance. A covered prescription at a $25 to $50 copay beats every figure here. Whether that is available is covered in Foundayo insurance coverage.
  • Staying at a lower dose. A dose that works is a dose worth staying on, and 9 mg costs the same $299 as the maximum while 5.5 mg does too. There is no financial reason to climb past a dose that is doing the job.
  • Missing the 45-day window. $50 a month, $600 a year, entirely avoidable by ordering at day 25 to 30.
  • Stopping. Weight tends to return after stopping any GLP-1, so the honest cost horizon is years rather than months — see whether weight regain can be prevented.

Scientific References

3 sources
  1. 1

    Eli Lilly and Company

    FOUNDAYO (orforglipron) self-pay pricing and savings programme terms, per-dose figures for a 30-day supply — verified August 2026

    Manufacturer pricing programme · 2026

  2. 2

    Novo Nordisk

    NovoCare Pharmacy self-pay pricing for Wegovy pen and tablets — verified August 2026

    Manufacturer pricing programme · 2026

  3. 3

    Eli Lilly and Company

    FOUNDAYO (orforglipron) tablets — Prescribing Information, §2.1 Dosage Escalation, §14 Table 6

    DailyMed, U.S. National Library of Medicine · 2026

    NIH

References open in a new tab. Content is reviewed against peer-reviewed literature as part of our editorial policy.

About the author

CG

Claudiu Gheorghe

Editor, Modern Weight Science

Claudiu Gheorghe is the editor of Modern Weight Science. He is not a physician. His role is to synthesize peer-reviewed studies, clinical-trial data, and FDA prescribing information into clear, plain-language explanations, and to make sure every factual claim on the site traces back to a cited source. Any decision about starting, changing, or stopping a medication belongs with a licensed clinician who knows your history.

Evidence synthesisGLP-1 and metabolic researchMedical editing and fact-checkingObesity and appetite science

Every claim is checked against peer-reviewed research through our review process and fact-checking policy.

Last updated 3 peer-reviewed sources cited

Frequently Asked Questions

How much does Foundayo cost per month?

Self-pay it runs $149 at the 0.8 mg starting dose, $199 at 2.5 mg, $299 at 5.5 and 9 mg, and $349 at 14.5 and 17.2 mg — reduced to $299 at those top two doses with the savings card. The card discounts nothing below 14.5 mg, so it is worth zero until you have titrated past 9 mg.

What does a year of Foundayo cost?

About $3,338 in year one with the savings card, because the five-month climb is spent on cheaper doses. Year two comes to about $3,588 — more than year one, since the titration discount is gone. Estimates that multiply the top price by twelve give $4,188 and overstate the first year by around $850.

Is Foundayo cheaper than Wegovy?

During titration, clearly: it starts at $149 against $199. At maintenance the two tablets cost the same, $299 a month, and Foundayo is $50 cheaper than the Wegovy pen at $349. So the claim that it is the cheapest branded GLP-1 is accurate at the start and stops being decisive once you reach the top dose.

Is Foundayo good value compared with Zepbound?

Not on results per dollar. Roughly $3,588 a year for 11.1% mean weight loss is about $323 per percentage point; Zepbound at $4,188 for 20.9% is about $200. The stronger drug is the more efficient purchase. That arithmetic is irrelevant to anyone who will not use an injection, which is the reason most Foundayo prescriptions exist.

How can I reduce what I pay for Foundayo?

Four ways. Check insurance first, since a covered prescription at a $25 to $50 copay beats every cash price. Refill within 45 days of your previous delivery to keep the $299 price at the top two doses, worth $600 a year. Do not climb past a dose that is working — 5.5 and 9 mg cost the same $299 as the maximum. And enrol in the savings card only once you reach 14.5 mg, since below that it changes nothing.

Continue learning

Where to read next

Not medical advice. This guide is for general education only. GLP-1 medications, dosing, and treatment suitability are decisions for you and a licensed clinician who knows your full medical history.

Continue reading

Related articles

Modern Treatments

Foundayo Results Week by Week: What the Timeline Really Shows

Foundayo results week by week: the label publishes weight at 72 weeks and no intermediate points. What it does give you is the titration timeline — full dose arrives around day 150.

7 min read·Updated August 2026
Read →
Modern Treatments

Foundayo Dosage: 0.8 mg to 17.2 mg, Step by Step

The full Foundayo dosage schedule from the label: six strengths, a minimum of 30 days each, and the two rules that can send you back down — a missed week, and a CYP3A4 interaction.

8 min read·Updated August 2026
Read →
Modern Treatments

Foundayo Side Effects: What the Label Reports, by Dose

Foundayo side effects from the FDA label, all four dose columns. Nausea reaches 35% at the maximum dose — between injected tirzepatide at 28% and injected semaglutide at 44%.

9 min read·Updated August 2026
Read →
Modern Treatments

Foundayo Insurance Coverage: What Plans Actually Pay

Foundayo insurance coverage in 2026: why weight-loss drugs get denied where diabetes drugs do not, what a new approval means for your formulary, and when self-pay is the better bet.

8 min read·Updated August 2026
Read →
Modern Treatments

What Is Foundayo? The First Oral GLP-1 Pill, Explained

What Foundayo is in plain terms: orforglipron, a daily tablet approved in April 2026 for weight loss — the first GLP-1 that is a small molecule rather than a peptide.

5 min read·Updated August 2026
Read →
Modern Treatments

Foundayo Weight Loss: What the Trials Actually Showed

Foundayo weight loss results from the FDA label, by dose and by threshold: 11.1% on average at the top dose, but 18.4% of patients lost at least a fifth of their body weight.

9 min read·Updated August 2026
Read →